Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine

Levin, Myron J., Smith, Jeffrey G., Kaufhold, Robin M., Barber, Debra, Hayward, Anthony R., Chan, Christina Y., Chan, Ivan S. F., Li, David J. J., Wang, William, Keller, Paul M., Shaw, Alan, Silber, Jeffrey L., Schlienger, Katia, Chalikonda, Ira, Vessey, S. J. R., Caulfield, Michael J.·2003·The Journal of Infectious Diseases
DOI 10.1086/379048

Cited by (314)

Items 201–300 of 314

  1. Herpes zoster ophthalmicus
    Jasmina Kovacevic, Arthur Mark Samia, Ankit A. Shah, Kiran Motaparthi · 2024 · Clinics in Dermatology
  2. Cytokine levels are associated with the severity of varicella infections
    Meijun Hao, Xiaojun Wang, Jingpei Du, Lifeng Liu, Yanmei Jiao, Hao Wu, Jiasheng Zheng, Wei Li · 2015 · The Journal of Infection in Developing Countries
  3. VSV: persistence in the population
    Jane F. Seward, Aisha Obad Jumaan · 2007 · Europe PMC (PubMed Central)
  4. Epidemiologic features of patients affected by herpes zoster: Database analysis of the Ferrara University Dermatology Unit, Italy
    Giovanni Gabutti, Carlotta Serenelli, Oriele Sarno, S. Marconi, Monica Corazza, Annarosa Virgili · 2009 · Médecine et Maladies Infectieuses
  5. Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults
    Marieke van der Heiden, Lia de Rond, Menno C. van Zelm, Guy A. M. Berbers, Annemieke M. H. Boots, Anne‐Marie Buisman · 2018 · Frontiers in Immunology
  6. VZV: persistence in the population: transmission and epidemiology
    Jane F. Seward, Aisha Obad Jumaan · 2007 · Cambridge University Press eBooks
  7. Varicella‐zoster virus‐specific, cell‐mediated immunity with interferon‐gamma release assay after vaccination of college students with no or intermediate IgG antibody response
    Kihei Terada, Yuri Itoh, Akihide FUJII, Seiko Kitagawa, Satoko Ogita, Kazunobu Ouchi · 2014 · Journal of Medical Virology
  8. Actualización en el tratamiento del herpes zóster
    Agustı́n España, Pedro Redondo · 2006 · Actas Dermo-Sifiliográficas
  9. Molecular and therapeutic aspects of varicella–zoster virus infection
    Mark Quinlivan, Judith Breuer · 2005 · Expert Reviews in Molecular Medicine
  10. Zoster Vaccine Live (Oka/Merck)
    Dean M Robinson, Caroline M. Perry · 2006 · Drugs & Aging
  11. Unraveling the Immune Signature of Herpes Zoster: Insights Into the Pathophysiology and Human Leukocyte Antigen Risk Profile
    Romi Vandoren, Marlies Boeren, Jolien Schippers, Esther Bartholomeus, Kerry A. Mullan, Nele R. M. Michels, Olivier Aerts, Julie Leysen, An Bervoets, Julien R. Lambert et al. · 2024 · The Journal of Infectious Diseases
  12. Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
    Irene Cassaniti, Alessandro Ferrari, Giuditta Comolli, Antonella Sarasini, Marilena Gregorini, Teresa Rampino, Daniele Lilleri, Fausto Baldanti · 2021 · Vaccines
  13. Varicella-Zoster Virus-Specific Enzyme-Linked Immunospot Assay Responses and Zoster-Associated Pain in Herpes Zoster Subjects
    Stephen Keith Tyring, Jon E. Stek, Jeffrey G. Smith, Jin Zhi Xu, Marco F. Pagnoni, Ivan S. F. Chan, Jeffrey L. Silber, Janie Parrino, Myron J. Levin · 2012 · Clinical and Vaccine Immunology
  14. Decreased Immunity to Varicella Zoster Virus in Giant Cell Arteritis
    Christien Rondaan, Kornelis S. M. van der Geest, Elisabeth Raveling‐Eelsing, Annemieke M. H. Boots, Nicolaas A. Bos, Johanna Westra, Elisabeth Brouwer · 2017 · Frontiers in Immunology
  15. Immunogenicity of the Varicella-Zoster Vaccine in Community-Dwelling Non-robust Elderly Individuals Compared to Robust Elderly Individuals: A Prospective Cohort Study
    Jung‐Yeon Choi, Min‐gu Kang, Kyoung Un Park, Wan Beom Park, Kwang‐Il Kim, Eu Suk Kim, Hong Bin Kim, Kyoung‐Ho Song, Cheol‐Ho Kim · 2018 · The Journals of Gerontology Series A
  16. Varicella immunization and herpes zoster.
    Antonio Volpi · 2005 · PubMed
  17. Varicella-zoster virus proteome-wide T-cell screening demonstrates low prevalence of virus-specific CD8 T-cells in latently infected human trigeminal ganglia
    Michiel van Gent, Werner J. D. Ouwendijk, Victoria Louise Campbell, Kerry J. Laing, Georges M. G. M. Verjans, David M. Koelle · 2023 · Journal of Neuroinflammation
  18. Characterization of neutralizing versus binding antibody and T cell responses to varicella-zoster virus in the elderly
    Suthee Mangmee, Supasek Kardkarnklai, Suphanun Phuphanitcharoenkun, Sarocha Suthisawat, Oranit Likhit, Nattaya Kamchompoo, Rae Apaivongse Coad, Patimaporn Wongprompitak, Jarupa Soongsathitanon, Tararaj Dharakul et al. · 2025 · Scientific Reports
  19. The surveillance of viral infections by the unconventional Type I NKT cell
    Varshini Rajashekar, Lauren Stern, Catarina F. Almeida, Barry Slobedman, Allison Abendroth · 2024 · Frontiers in Immunology
  20. Cerebrovascular events after herpes zoster infection: a risk that should be not underestimated
    Marco Zuin, Gianluca Rigatelli, Alessandro Adami · 2019 · Journal of NeuroVirology
  21. Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
    Insaf Salem Fourati, Anne-Julie Grenier, Élyse Jolette, Natacha Mérindol, Philippe Ovetchkine, Hugo Soudeyns · 2014 · Journal of Visualized Experiments
  22. Human Herpesvirus Infections
    S. David Hudnall, Lawrence Raymond Stanberry, P. D. Griffiths · 2011 · Elsevier eBooks
  23. Elderly immunocompetent man presenting with disseminated cutaneous herpes zoster
    Uddalak Chakraborty, Atanu Chandra, Abheek Sil, Surajit Kumar Biswas · 2020 · BMJ Case Reports
  24. Vacunación frente al herpes zoster
    L. Salleras, Montse Salleras · 2014 · Vacunas
  25. Global burden of varicella and herpes zoster across 204 countries, 1990–2021: a temporal trend analysis in the era of the COVID-19 pandemic and projections to 2036
    Zilun Wu, Jinbu Zhang, Jiahao Wei, Chenjin Huang, Wenfeng Xu, Jiaqiang Wu, Meirong Jiang · 2025 · Frontiers in Public Health
  26. Prophylactic vaccination with a live-attenuated herpes zoster vaccine in lung transplant candidates
    Lei Wang, Erik A.M. Verschuuren, Davy Paap, Christien Rondaan, Elisabeth Raveling‐Eelsing, Johanna Westra, Nicolaas A. Bos · 2020 · The Journal of Heart and Lung Transplantation
  27. VARICELLA-ZOSTER VIRUS
    Anne A. Gershon · 2009 · Elsevier eBooks
  28. Varicella zoster virus and cardiovascular diseases
    Angelica Cersosimo, Mauro Riccardi, Ludovica Amore, Giuliana Cimino, Gianmarco Arabia, Marco Metra, Enrico Vizzardi · 2022 · Monaldi Archives for Chest Disease
  29. The silent war against CMV in CLL
    Arne N. Akbar · 2010 · Blood
  30. Vacunas frente al virus de la varicela zóster
    Luis Salleras, Montse Salleras, Núria Soldevila, Andrés Prat, Patricio Garrido, Ángela Domı́nguez · 2015 · Enfermedades Infecciosas y Microbiología Clínica
  31. Comparative risk of herpes zoster in patients with psoriatic disease on systemic treatments: a systematic review and network meta-analysis
    Hsien‐Yi Chiu, Wen-Hung Chung, Shi‐Wei Huang, Yu‐Huei Huang · 2022 · Therapeutic Advances in Chronic Disease
  32. Varicella zoster virus antibody detection: A comparison of four commonly used techniques
    Naruhito Otani, Miyuki Tanaka, Kazuhiro Maeda, Yasuyuki Gomi, Kazuhiko Nakajima, Susumu Tanimura, Yoshio Takesue, Masayuki Shima, Toshiomi Okuno · 2016 · Journal of Infection and Chemotherapy
  33. Herpes zoster incidence in adults aged ≥ 20 years in Finland, 2015 to 2023: a population-based register study
    Aapo Juutinen, Heini Salo, Toni Lehtonen, Tuija M. Leino · 2025 · Eurosurveillance
  34. Immunogenicity of varicella-zoster virus vaccine by different routes of administration: Comparable vaccination efficacy of one-fifth dose intradermal vaccination to conventional subcutaneous vaccination
    Yuki Nakamura-Nishimura, Satoru Shinkuma, Fumi Miyagawa, Ahmad M. Haredy, Yasuyuki Gomi, Koichi Yamanishi, Hideo Asada · 2022 · Journal of Dermatological Science
  35. Herpes zoster vaccination in the elderly subjects: improving awareness and uptake
    Giovanni Gabutti, Armando Stefanati, Nicoletta Valente, Silvia Lupi, Sara Previato, Matilde Giordani · 2015 · Patient Intelligence
  36. Varicella Zoster Virus–Specific Immune Response after Treatment with Sodium Stibogluconate for Cutaneous Leishmaniasis
    In‐Kyu Yoon, Josephine H. Cox, Yaling Zhou, Yvonne D. Lukes, Brian J. Reinhardt, Anais Valencia-Micolta, Glenn W. Wortmann · 2008 · American Journal of Tropical Medicine and Hygiene
  37. Intramuscularly administered herpes zoster subunit vaccine has no effects on fertility, pre- and post-natal development in Sprague-Dawley rats
    Lawrence M. Segal, Karen Thacker, Michel Fochesato, Giulia Giordano, Nathalie Garçon, Éric Destexhe · 2017 · Reproductive Toxicology
  38. Comprehensive review and update on herpes zoster
    Young Min Park · 2018 · Journal of Korean Medical Association
  39. Evaluation of Varicella‐zoster virus‐specific cell‐mediated immunity by interferon‐γ Enzyme‐Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine
    Ping Chang Yang, Zhen Chen, Jieqiong Zhang, Wei Li, Changlin Zhu, Ping Qiu, Yaru Quan, Xiaoyu Cui, Liyong Yuan, Chunlai Jiang · 2019 · Journal of Medical Virology
  40. Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster A population-based study from primary care in Madrid (Spain)
    Rey Juan · 2014
  41. VZV infection: epidemiology and prevention
    Giovanni Gabutti · 2015 · Journal of preventive medicine and hygiene
  42. Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4high memory cell proliferation in activated whole blood cultures
    Ahmad M. Haredy, Michihiro Takei, Shin-ichi Iwamoto, Masafumi Ohno, Mitsuyo Kosaka, Kazue Hirota, Ritsuko Koketsu, Toshiomi Okuno, Kazuyoshi Ikuta, Koichi Yamanishi et al. · 2019 · Vaccine
  43. Disseminated Herpes Zoster on a Child with Systemic Lupus Erythematosus and Lupus Nephritis
    Dhelya Widasmara, Fitri Firdausiya · 2021 · Infection and Drug Resistance
  44. Genetic Evidence Indicates that Serum Micronutrient Levels Mediate the Causal Relationships Between Immune Cells and Neuropathic Pain: A Mediation Mendelian Randomization Study
    Shaopeng Shi, Shaier Yang, Peng Ma, Yi Wang, Chunxiang Ma, Ma Wan · 2025 · Molecular Neurobiology
  45. The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation
    Francesco Nicoli, Eleonora Gallerani, Mariaconcetta Sicurella, Salvatore Pacifico, Aurelio Cafaro, Barbara Ensoli, Peggy Marconi, Antonella Caputo, Riccardo Gavioli · 2020 · Vaccines
  46. Validation of coding algorithms for the identification of herpes zoster among children
    Beth H. Rutstein, Sabrina Gmuca, Jeffrey S. Gerber, Tristan Lim, Melissa Argraves, Alexis Ogdie · 2021 · Pharmacoepidemiology and Drug Safety
  47. Th1 regulatory events by infectious pathogens, herpes zoster and herpes simplex viruses: prospects for therapeutic options for atopic eczema
    Yasuhiro Horiuchi · 2022 · Advances in Dermatology and Allergology
  48. Predictors of Shingles Reports at Diagnosis of Common Variable Immunodeficiency and Selective Immunoglobulin G Subclass Deficiency in 212 Alabama Adults
    James C. Barton, James C. Barton, Luigi F. Bertoli · 2012 · Infectious Disease Reports
  49. A model of varicella-zoster reactivation
    Jonathan E. Forde, Bailey Meeker · 2010 · Mathematical Biosciences & Engineering
  50. Shingles vaccine
    C. Beau Willison, L Katie Morrison, Natalia Mendoza, Stephen Keith Tyring · 2010 · Expert Opinion on Biological Therapy
  51. Vacunación frente al herpes zóster
    L.L. Salleras, Montse Salleras · 2010 · Vacunas
  52. Safety, long-term effectiveness, and immunogenicity of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy
    Maša Bizjak, Jakob Peterlin, Tadej Avčin, Miroslav Petrovec, Alojz Ihan, Mojca Zajc Avramovič, Gašper Markelj, Tina Vesel Tajnšek, Veronika Osterman, Jerneja Ahčan et al. · 2025 · Vaccine X
  53. Definition and management of varicella zoster virus-associated meningoradiculitis: a case report
    Vincent Luisier, Lalensia Weber, Daniel Fishman, Gérard Praz, Joseph-André Ghika, Didier Genoud, Joëlle Nsimire Chabwine · 2016 · BMC Research Notes
  54. A Simple-to-Perform ifn-γ mRNA Gene Expression Assay on Whole Blood Accurately Appraises Varicella Zoster Virus-Specific Cell-Mediated Immunity After Allogeneic Hematopoietic Stem Cell Transplantation
    Mathilde Boccard, Anne Conrad, William Mouton, Florent Valour, Chantal Roure-Sobas, Émilie Frobert, Barbara Rohmer, Vincent Alcazer, Hélène Labussière‐Wallet, Hervé Ghesquières et al. · 2022 · Frontiers in Immunology
  55. Varicella Vaccines
    Maria A. Nagel, Anne A. Gershon, Ravi Mahalingam, Christy S. Niemeyer, Andrew N. Bubak · 2023 · Elsevier eBooks
  56. The frequency of interleukin-1β-producing monocytes is significantly associated with varicella-zoster responses of nursing home residents
    Elie Picard, Dawn M. E. Bowdish, Janet E. McElhaney, Graham Pawelec, Mark B Loeb, Chris P. Verschoor · 2021 · Clinical & Experimental Immunology
  57. RESPONDER CELL FREQUENCY ESTIMATION AND BINOMIAL THREE-LEVEL NONLINEAR MIXED EFFECTS MODEL IN LIMITING DILUTION ASSAYS
    Misoo C. Ellison, Gary O. Zerbe, Myron J. Levin · 2004 · Journal of Biopharmaceutical Statistics
  58. Les vaccins contre le zona : efficacité, sécurité, et rapport coût/bénéfices
    Nabila Ferahta, Imene Achek, Julie Dubourg, Pierre Olivier Lang · 2015 · La Presse Médicale
  59. Varicella-zoster vaccine in the USA: success for control of disease severity, but what next?
    Barbara A. Watson · 2005 · Expert Review of Anti-infective Therapy
  60. Preventive Effectiveness of Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors
    Yusuke Tabata, Shun Tanimura, Akemi Kitano, Yuhei Shibata, Ikuma Nakagawa, Megumi Matsuhashi, Masato Shimizu, Kazuhide Tanimura, Takao Koike · 2025 · Internal Medicine
  61. Memory T cell aging and rejuvenation
    Sarah Adamo, Joel G. Rurik, Claire E. Gustafson, Marcus Buggert · 2026 · Immunity
  62. Varicella Zoster Virus
    Anne A. Gershon · 2025 · Elsevier eBooks
  63. Glucocorticoids – Efficient analgesics against postherpetic neuralgia?
    Mette Richner, Christian Bjerggaard Vægter · 2017 · Scandinavian Journal of Pain
  64. Immunosenescence Modulation by Vaccination
    Janet E. McElhaney · 2019 · Springer eBooks
  65. Varicella-Zoster Virus Reactivation During the Incubation Period for Scrub Typhus: A Case Report
    Byeongcheol Lee, Daeseok Oh, Hyun-Seong Lee, Myoung Jin Ko, Ji Yeon Kwon, Dae Yun Choi, Kyeong Min Jo · 2022 · American Journal of Case Reports
  66. Effectiveness of Live Attenuated Varicella-Zoster Vaccine in Adults Older than 50 Years in Japan: A Retrospective Cohort Study
    Kazuhiro Matsumoto, Satoko Ohfuji, Kana Inohara, Masateru Akechi, Hiroko Kumashiro, Motoki Ishibashi, Shin Irie, Yoshio Hirota · 2023 · Vaccines
  67. Immune Response to an Adjuvanted Recombinant Zoster Vaccine in Japanese Patients with Rheumatoid Arthritis Receiving Upadacitinib (End Zoster-J Study): Study Protocol for an Exploratory Parallel Triple-Arm Prospective Trial
    Ryu Watanabe, Hisako Fujii, Takumi Imai, Yuki Furusawa, Masao Katsushima, Kazuo Fukumoto, Yutaro Yamada, K. Mamoto, Tadashi Okano, Shinsuke Yamada et al. · 2024 · Journal of Clinical Medicine
  68. Clinical epidemiology of herpes zoster and postherpetic neuralgia in Barcelona (Spain). A single-center study
    Montse Salleras, Patricia Salvador, Lluís Salleras, Núria Soldevila, Andreu A. Prat, Patricio Garrido, Ángela Domı́nguez · 2026 · Frontiers in Public Health
  69. Post-COVID varicella-zoster virus reactivation: lowering the immunological threshold for latency breakdown
    Xiaolu Li, Shuchang Cheng, Siqi Wang, Kaili Gao, Yang Bai, Sainan Li, Mingchun Gao, Yongli Guo · 2026 · Frontiers in Cellular and Infection Microbiology
  70. Herpes Zoster in a World Class Triathlete: A Case Report and Evaluation of Training Schedules in Relation to Immune Status
    Lawrence P. Lai, Jeffrey S. Shilt, John S. Georgy · 2015 · International Journal of Sport and Health Science
  71. Tres casos de erupción generalizada vesiculoampollosa: un reto diagnóstico
    J. Sánchez-López, I. Sánchez-López, Miguel Antonio Díaz‐Martinez, Ana Almódovar-Real, Ricardo Ruíz‐Villaverde · 2015 · Medicina de Familia SEMERGEN
  72. Clinical Features of Herpes Zoster in Children according to Immune Status
    최영빈, 권영세, 김동현 · 2018 · Annals of Child Neurology
  73. Routine Adult Vaccines and Boosters
    Ursula Wiedermann · 2013 · Elsevier eBooks
  74. Immunosenescence Modulation by Vaccination
    Janet E. McElhaney · 2017 · Springer eBooks
  75. Psychiatric Disorders and Their Impact on Herpes Zoster Incidence: Five Years of Data from Turkiye
    Caner Yeşiloğlu, Cihan Yeşiloğlu, Lut Tamam, Mehmet Emin Demirkol · 2024 · Journal of Clinical Medicine
  76. Herpes Varicella Zoster: The Other Pox (Chickenpox)
    Van G. Wilson · 2025 · Springer eBooks
  77. Immunoprophylaxis of Viral Diseases
    Stephen C. Hadler, Jane F. Seward · 2010 · Wiley eBooks
  78. Concordance of Human Papillomavirus (HPV) Type between Sex Partners: Implications for Effective Utilization of an HPV Vaccine
    Lori Panther · 2005 · Clinical Infectious Diseases
  79. Frequently asked questions about varicella vaccine
    Wonie Uahwatanasakul, Jonathan Rhys Carapetis · 2005 · Australian Prescriber
  80. Vaccines
    Anita Arora, Natalia Mendoza, Anne Marie Tremaine, Stephen Keith Tyring · 2008 · Springer eBooks
  81. Immune response to an adjuvanted recombinant zoster vaccine in Japanese patients with rheumatoid arthritis receiving upadacitinib (End Zoster-J study)
    Ryu Watanabe, Hisako Fujii, Takumi Imai, Yuki Furusawa, Masao Katsushima, Kazuo Fukumoto, Yutaro Yamada, K. Mamoto, Tadashi Okano, Shinsuke Yamada et al. · 2024 · Research Square
  82. Schutz vor Zoster
    S. W. Wassilew, Peter Wutzler · 2010 · Prävention und Gesundheitsförderung
  83. Zoster vaccine for the elderly
    David E. Michalik, Anne A. Gershon · 2006 · Drug Discovery Today Therapeutic Strategies
  84. Immunosenescence Modulation by Vaccination
    Janet E. McElhaney · 2009 · Springer eBooks
  85. A shot in the arm for immunotherapy
    P. D. Griffiths · 2005 · Reviews in Medical Virology
  86. Reducing the Burden of Herpes Zoster and Postherpetic Neuralgia Through Vaccination
    Michael D. Hogue, Robert D. Arbeit, Lawrence D. Gelb · 2006 · The Consultant Pharmacist
  87. Formación médica continuada: Actualización en vacunas Vacunas frente al virus de la varicela zóster
    Luis Salleras, Montse Salleras, Núria Soldevila, Andrés Prat, Patricio Garrido, Ángela Domı́nguez · 2016
  88. Simian varicella virus and varicella-zoster virus immune evasion of NFkB activation
    Travis Whitmer · 2015
  89. Ischemia-modified albumin (IMA) and dynamic thiol-disulfide homeostasis in patients with postherpetic neuralgia
    Şule Arıcan, Gülçin Hacıbeyoğlu, Sinan Oguzhan Ulukaya, Gamze Avcıoğlu, Ruhıye Reıslı, Sema Tuncer Uzun, Özcan Erel · 2019 · Journal of Laboratory Medicine
  90. New Pharmacotherapeutic Posssibilities in Contemporary Dentistry
    Radovan Slezák, Zuzana Janovská, I. Lindrová, Vladimíra Radochová · 2015 · Česká stomatologie a praktické zubní lékařství
  91. Herpes zoster prevention. Vaccine blocks viral reactivation
    S. W. Wassilew, Peter Wutzler · 2010 · Prävention und Gesundheitsförderung
  92. Ageing Mucosal Immunity and Its Consequences for Infectious Diseases in the Aged; A First Glance
    Marieke van der Heiden, Debbie van Baarle · 2021 · Healthy ageing and longevity
  93. Vaccination chez l’adulte: vaccins contre le zona et vaccination en cas d’asplénie anatomique ou fonctionnelle
    Aline Munting, Pierre Alex Crisinel · 2021 · JMIG
  94. Vaccines
    Michael Lee, Christopher P. Downing, Ramya Kollipara, Jacqueline A. Guidry, Stephen Keith Tyring · 2017 · Springer eBooks
  95. Vaccines against viral infections
    Janet E. McElhaney · 2017 · Oxford University Press eBooks
  96. Zona
    Jacques Gaillat · 2020 · Revue des Maladies Respiratoires Actualités
  97. Diabetes and Herpes Zoster Association: A systematic Review and Meta-analysis
    Mohammad Hossein Razizadeh, Alireza Khatami, Kumars Pourrostami, Farah Bokharaei‐Salim, Mohammad Zibaei · 2022 · International Journal of Enteric Pathogens
  98. Unraveling the immune signature of herpes zoster: Insights into pathophysiology and the HLA risk profile
    Romi Vandoren, Marlies Boeren, Jolien Schippers, Esther Bartholomeus, Nele R. M. Michels, Olivier Aerts, Julie Leysen, An Bervoets, Julien R. Lambert, Elke E. Leuridan et al. · 2023 · medRxiv
  99. A transient reduction of the varicella-zoster virus-specific immunoglobulin G level after vaccination against severe acute respiratory syndrome coronavirus 2 with an mRNA vaccine in nursing home residents, but not staff
    Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, Takahisa Shimada, Kei Fukuyama, Kazunori Oishi, Hideki Tani · 2025 · Journal of Infection and Chemotherapy
  100. Varicella zoster virus reactivation episodes and vaccination uptake in Spleen Australia registrants
    Gabriela Khoury, Tim D. Spelman, Penelope Jones, Nenad Maćešić, Denis Spelman, Ian John Woolley · 2025 · Vaccine